Charlie Teo Foundation is funding the study by a respected US cancer researcher of a potential new Australian drug discovery to help treat GBM, the most aggressive type of brain cancer.
We encouraged this collaboration between Australian pharmaceutical research company Pharmaxis and Dr Alan Wang from MD Anderson, one of the most prestigious comprehensive cancer centres in the USA.
Dr Teo and our team were thrilled to visit the Pharmaxis team in their drug discovery labs to announce this news, along with National Nine News and medical reporter Gabriella Rogers.
Charlie Teo Foundation brings together who we consider to be the best brains from around the world for the benefit of Australian patients. We’re proud to announce this exciting research this Brain Cancer Awareness Month!